Search results (27)
« Back to NewsNew DPhil studentships in Cancer Science available for 2024 intake
30 October 2023
Boccellato Byrne Lu Rittscher Schuster-Böckler Tomkova Van den Eynde White
Ludwig Oxford supervised DPhil studentships in Cancer Science are now being advertised for the 2024 intake
A role for ASPP2 in Hepatitis C infection
28 September 2023
Ludwig Oxford researchers in the Lu lab uncover new insights into the role of ASPP2 in Hepatitis C virus replication and transmission.
Ludwig Oxford clinical trial shows Immunochemotherapy outcomes predicted by tumour monocyte content
11 July 2023
Lu Schuster-Böckler Van den Eynde
An analysis of samples obtained from a uniquely designed window-of-opportunity clinical trial (LUD2015-005) has shown that high tumour monocyte content (TMC) is an unexpected predictor of greater overall survival in inoperable oesophageal adenocarcinoma (OAC) patients.
p53 inhibitor iASPP acts as a surprise pancreatic cancer suppressor
9 June 2023
Ludwig Oxford’s Xin Lu shows an unexpected suppression of KRAS and inflammation driven pancreatic cancer by the p53 suppressor iASPP.
iASPP as a regulator of immunological tolerance
6 February 2023
Researchers from the Lu lab identify iASPP to be a key component in the anti-tumour immune response
Professor Xin Lu featured in Ludwig's Women in Science report
24 November 2022
Ludwig Oxford’s Professor Xin Lu recounts her experiences in Ludwig Cancer Research’s special Women in Science report.
Ludwig Oxford student awarded NDM graduate student prize
18 November 2022
Dr Tom Carroll from the Lu lab receives a Highly Commended award under the NDM overall graduate student prize
Mechanistic insights into the ZBP1 inflammatory response
21 October 2022
A collaborative study, led by former Ludwig Oxford group leader Professor Mads Gyrd-Hansen, sheds light on the ZBP1-induced signalling pathway, a pathway which contributes to the viral immune response, including to SARS-CoV-2
Unexpected role of iASPP as a tumour suppressor
18 October 2022
The Lu lab reveals that the previously characterised oncogene, iASPP, acts as a tumour suppressor in mutant RAS- and inflammation-driven skin cancers.
Mathematical methods for analysing single-cell transcriptomic data
17 August 2022
An interdisciplinary collaboration has resulted in the development of three multiscale data methods for the analysis of single-cell transcriptomic data that have advantages over current methods.
Ludwig Oxford student features in the Oxford Botantic Garden 400th Anniversary celebrations
2 August 2022
On Saturday 30th July, PhD student Hannah Fuchs gave a soapbox talk on plant-derived cancer treatments.
Ludwig Oxford Director Professor Xin Lu elected as Academia Europaea member
19 July 2022
Professor Xin Lu joins >4600 other eminent academic members from across Europe.
Ludwig Oxford retreat 2022 – a recap
15 July 2022
Barnes Boccellato Byrne Constantinescu De Val Goding Kriaucionis Lu Mehdipour Moura Alves Ratcliffe Schuster-Böckler Shi Song Van den Eynde
On 13-14th June 2022, the Oxford Branch of the Ludwig Institute for Cancer Research held their annual retreat to discuss key scientific advances within the Branch and beyond.
Unexpected hydroxylation
20 May 2022
Biochemical and structural data reveals a site on ankyrin repeat domain proteins for double hydroxylation by Factor Inhibiting Hypoxia Inducible Factor (FIH).
Ludwig Oxford at AACR 2022
8 April 2022
Several Ludwig Oxford researchers present at the American Association for Cancer Research (AACR) Annual Meeting.
UNIQ summer school 2021
22 July 2021
Kriaucionis Lu Public Engagement Van den Eynde
Three Ludwig Oxford volunteers participate at the 2021 Oncology UNIQ summer school
AI endoscopy enables 3D surface measurements of pre-cancerous condition in oesophagus
9 June 2021
Clinicians and engineers in Oxford have begun using artificial intelligence alongside endoscopy to get more accurate readings of the pre-cancerous condition Barrett’s oesophagus and so determine patients most at risk of developing cancer.
CRUK Oxford Centre Development Fund awarded to Dr Linna Zhou
2 June 2021
Ludwig Oxford’s Dr Linna Zhou will investigate the role of the nervous system in cancer progression using engineered gastrointestinal tissues.
Celebrating 100 years of women in Oxford Medical Sciences
11 February 2021
Ludwig Oxford Director Professor Xin Lu features in this showcase of women in diverse roles across Oxford’s Medical Sciences Division.
Drugging p53
4 January 2021
The drug arsenic trioxide can restore the structure and function of some p53 tumour suppressor mutants, with potential as a future personalised cancer treatment strategy.